1. Flaherty, Stephen E, Bezy, Olivier, Zheng, Wei, Fortin, Jean-Philippe, Wu, Zhidan. 2023. Chronic UCN2 treatment desensitizes CRHR2 and improves insulin sensitivity. In Nature communications, 14, 3953. doi:10.1038/s41467-023-39597-w. https://pubmed.ncbi.nlm.nih.gov/37402735/
2. Amin, Mutaz, Ott, Jurg, Gordon, Derek, Vergare, Michael, Gragnoli, Claudia. 2022. Comorbidity of Novel CRHR2 Gene Variants in Type 2 Diabetes and Depression. In International journal of molecular sciences, 23, . doi:10.3390/ijms23179819. https://pubmed.ncbi.nlm.nih.gov/36077219/
3. Pothoulakis, Charalabos, Torre-Rojas, Monica, Duran-Padilla, Marco A, Chalkiadakis, George, Baritaki, Stavroula. 2017. CRHR2/Ucn2 signaling is a novel regulator of miR-7/YY1/Fas circuitry contributing to reversal of colorectal cancer cell resistance to Fas-mediated apoptosis. In International journal of cancer, 142, 334-346. doi:10.1002/ijc.31064. https://pubmed.ncbi.nlm.nih.gov/28929494/
4. Crunkhorn, Sarah. . Cardiovascular disease: CRHR2 blockade prevents heart failure. In Nature reviews. Drug discovery, 16, 530. doi:10.1038/nrd.2017.142. https://pubmed.ncbi.nlm.nih.gov/28757621/
5. Bozzatello, Paola, Rocca, Paola, Baldassarri, Lorenzo, Bosia, Marco, Bellino, Silvio. 2021. The Role of Trauma in Early Onset Borderline Personality Disorder: A Biopsychosocial Perspective. In Frontiers in psychiatry, 12, 721361. doi:10.3389/fpsyt.2021.721361. https://pubmed.ncbi.nlm.nih.gov/34630181/